Neuroendocrine Carcinoma Clinical Trials
0 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 3
Tarlatamab vs Standard of Care Chemotherapy in Patients With Pre-treated Advanced, Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Carcinomas (NECs)
Neuroendocrine Carcinoma
Intergroupe Francophone de Cancerologie Thoracique129 enrolled40 locationsNCT06937905
Recruiting
Phase 1Phase 2
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd54 enrolled1 locationNCT05978284
Recruiting
Phase 1Phase 2
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Small Cell Lung CancerNeuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd350 enrolled1 locationNCT07038096
Recruiting
Clinical Application of the J-PET Scanner Prototype
Prostate CancerNeuroendocrine TumorsProstate Cancer Metastatic+3 more
Jagiellonian University25 enrolled1 locationNCT06242119
Recruiting
Phase 1Phase 2
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
Neuroendocrine Carcinoma
Suzhou Zelgen Biopharmaceuticals Co.,Ltd78 enrolled1 locationNCT06440057
Recruiting
PrognostIc and Predictive Factors in Unresectable Locally Advanced NEC and MANEC
Neuroendocrine Carcinoma
European Institute of Oncology100 enrolled1 locationNCT06400654
Recruiting
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Non-small Cell Lung CancerNeuroendocrine CarcinomaHistology Transformation
Fudan University50 enrolled1 locationNCT06369181